Similar articles

• [Treatment of Basedow's disease].

  Bürgi H. Bürgi H. Rev Med Suisse Romande. 1975 May;95(5):325-43. Rev Med Suisse Romande. 1975. PMID: 52173 French. No abstract available.
• Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.

  Bojarska-Szmygin A, Janicki K, Pietura R, Janicka L. Bojarska-Szmygin A, et al. Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):248-53. Ann Univ Mariae Curie Sklodowska Med. 2003. PMID: 15314994 Clinical Trial.
• [Hyperthyreosis in Basedow's disease].

  Välimäki MJ. Välimäki MJ. Duodecim. 1998;114(5):447-54. Duodecim. 1998. PMID: 11466937 Review. Finnish. No abstract available.
• Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.

  Das PK, Wherrett D, Dror Y. Das PK, et al. Pediatr Blood Cancer. 2007 Aug;49(2):210-2. doi: 10.1002/pbc.20640. Pediatr Blood Cancer. 2007. PMID: 16456859
• Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?

  Bogazzi F, Martino E, Bartalena L. Bogazzi F, et al. J Endocrinol Invest. 2003 Feb;26(2):174-6. doi: 10.1007/BF03345148. J Endocrinol Invest. 2003. PMID: 12739747 Review. No abstract available.